Current Topics in Medicinal Chemistry
Title: Editorial [Hot Topic: Metabotropic Glutamate Receptors: Medicinal Chemistry and Therapeutic Implications (Guest Editor: Craig W. Lindsley)]
Volume: 5 Issue: 9
Author(s): Craig W. Lindsley
Affiliation:
Export Options
About this article
Cite this article as:
Lindsley W. Craig, Editorial [Hot Topic: Metabotropic Glutamate Receptors: Medicinal Chemistry and Therapeutic Implications (Guest Editor: Craig W. Lindsley)], Current Topics in Medicinal Chemistry 2005; 5 (9) . https://dx.doi.org/10.2174/1568026054750308
DOI https://dx.doi.org/10.2174/1568026054750308 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges
Current Cancer Drug Targets Amyloid β Accumulation Assessed with <sup>11</sup>C-Pittsburgh Compound B PET and Postmortem Neuropathology
Current Alzheimer Research Frailty Among Alzheimer’s Disease Patients
CNS & Neurological Disorders - Drug Targets An Efficient One-Step Hantzsch Multicomponent Synthesis of 1,4- Dihydropyridines Via a Wells-Dawson Heteropolyacid Catalyst Under Solvent-Free Conditions
Letters in Organic Chemistry Functional Consequences of Locus Coeruleus Degeneration in Alzheimers Disease
Current Alzheimer Research Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical Biotechnology Fetal Alcohol Syndrome: A Cautionary Note
Current Pharmaceutical Design Butyrylcholinesterase K and Apolipoprotein ε4 Affect Cortical Thickness and Neuropsychiatric Symptoms in Alzheimer’s Disease
Current Alzheimer Research Borderline features in Youth with Bipolar Spectrum Disorders
Adolescent Psychiatry Neurodegenerative Diseases Associated with Mitochondrial DNA Mutations
Current Pharmaceutical Design Novel Anticancer Dimeric Naphthoquinones from <i>Diospyros lotus</i> having Anti- Tumor, Anti-Inflammatory and Multidrug Resistance Reversal Potential: <i>In Vitro, In Vivo</i> and <i>In Silico</i> Evidence
Anti-Cancer Agents in Medicinal Chemistry Glial Cells – The Key Elements of Alzheimer´s Disease
Current Alzheimer Research Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease
Current Alzheimer Research Anti-cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer
Current Drug Metabolism Nitric Oxide and Dietary Factors: Part I Nitric Oxide Synthesis and Action
Vascular Disease Prevention (Discontinued) Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs
Current Pharmaceutical Design Optimization of Extraction and Pre-Concentration of Rizatriptan in Biological Samples Using Solvent Bar and Chemometrics Design
Current Pharmaceutical Analysis Meet Our Editor
Neuroscience and Biomedical Engineering (Discontinued) Application of the In Combo Screening Approach For the Discovery of Non-Alkaloid Acetylcholinesterase Inhibitors from Cichorium intybus
Current Drug Discovery Technologies Editorial
Recent Patents on CNS Drug Discovery (Discontinued)